drugset / Trial / NCT02085239

Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

NCT02085239 ↗

Phase 4 Withdrawn TriHealth Inc.
RandomizedParallel-groupSingle-blindSupportive care

Summary

This study will evaluate the potential role of a long acting anesthetic (ropivacaine) in providing an extended period of pain relief for patients undergoing ultrasound guided core biopsy of the breast.

Timeline

Start
2013-08
Primary completion
2015-03
Completion
2015-03

Outcome

Outcome not reported

Stopped: “Study never got started; can't delete results”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 8 ml Subcutaneous
Subject Ropivacaine Other / unclassified 10 ml Subcutaneous
Comparator Lidocaine Other / unclassified 8 ml Subcutaneous
Comparator Lidocaine Other / unclassified 10 ml Subcutaneous

Indications

No indication recorded.